Cardiac Arrhythmia Monitoring Devices Market – Detailed Analysis of Current Industry Figures with Forecasts Growth By 2025

Market Study Report LLC has a newly added "Global Cardiac Arrhythmia Monitoring Devices Market Report" that gives meticulous investigation of current scenario of the market share, demand, growth, trends, and forecast in the coming years.

Growing burden of cardiovascular disorders will escalate the demand for heart arrhythmia monitoring devices in the upcoming years. The incidence of various cardiac dysrhythmias such as atrial flutter, bradycardia, atrial fibrillation among others is rising at a rapid pace. As per the Public Health England, approximately 1.4 million people are suffering from atrial fibrillation, along with numerous undiagnosed cases of the disease. Such heart condition require timely and precise monitoring of the heart rhythm, thereby boosting the adoption of cardiac arrhythmia monitoring devices over the forecast years.

Request a sample of this premium report at:

Global Cardiac Arrhythmia Monitoring Devices Market will reach over USD 8.0 billion by 2025; as per a new research report. Development of telemetric and mobile cardiac arrythmia monitoring solutions will impel the global cardiac arrhythmia monitoring devices market growth in the forthcoming years. Mobile cardiac telemetry is required in case of individuals, having cryptogenic stroke history. Additionally, mobile cardiac telemetry solutions offer automated reports based on patient’s heart rhythm. A novel solution, named, MoMe Kardia, makes cardiac rhythm data available continuously to the physicians for analysis, with full disclosure on a HIPAA-compliant portal. Such innovative devices, catering to the changing needs of patients and physicians will stimulate the market growth in the coming period.

U.S. cardiac arrhythmia monitoring devices market accounted for more than 90% market share of the North America cardiac arrhythmia monitoring devices market. High growth can be attributed to increasing incidence of cardiovascular diseases (CVDs) coupled with expanding geriatric pool susceptible to various CVDs. Also, rising burden of obese population pose a primary risk factor in the development of CVDs. Thus, with increasing disease pervasiveness along with introduction of innovative arrhythmia detection monitors, U.S. cardiac arrhythmia monitoring devices industry is set to boost over the forthcoming years.

Holter monitor device market is estimated to progress at 6.0% CAGR during the forecast years. Holter monitor offers continuous monitoring and recording of the heart?s rhythm, even during an individual’s daily activities. It also provides assessment of patients with coronary artery disease. In addition, Holter monitors are covered by private payers as well as Medicaid, thus influencing higher customer adoption and lucrative segmental growth.

Home settings segment held USD 508.0 million revenue size in 2018. Growing patient preference for homecare devices will fortify the demand for cardiac arrythmia monitoring devices at home settings. Consumers prefer convenient and user-friendly devices for self-monitoring and management of disorder. Thus, emergence of portable and hand-held devices for monitoring heart rhythm will offer lucrative segmental growth in the foreseeable years.

Request a discount on standard prices of this premium report at:

The demand for cardiac arrythmia monitors for tracking tachycardia will grow at robust pace of 6.8% CAGR in the projection years. Tachycardia being the most common form of arrhythmia, is estimated to offer significant segmental growth. Atrial fibrillation is commonly diagnosed form of tachycardia and affects more than 2 million Americans. With rising adoption of unhealthy lifestyle and eating habits, tachycardia segment is projected to expand over the future years.

Some of the major companies competing in the global cardiac arrhythmia monitoring devices market are Abbott Laboratories, iRhythm Technologies, AliveCor, and Biotronik, among few others. Industry players are focusing on product introduction and expansion strategies, to broaden their product base as well as customer portfolio. For instance, in May 2019, Abbott Laboratories introduced Confirm Rx, a paperclip-sized insertable cardiac monitor, offering an option to synchronize with a mobile via Bluetooth, thereby fortifying its product offerings.

Table of Content:

Chapter 1. Methodology

Chapter 2. Executive Summary

Chapter 3. Cardiac Arrhythmia Monitoring Devices Industry Insights

Chapter 4. Cardiac Arrhythmia Monitoring Devices Market, By Device

Chapter 5. Cardiac Arrhythmia Monitoring Devices Market, By End-use

Chapter 6. Cardiac Arrhythmia Monitoring Devices Market, By End-use

Chapter 7. Cardiac Arrhythmia Monitoring Devices Market, By Region

Chapter 8. Cardiac Arrhythmia Monitoring Devices Market Company Profiles

For more information on this report at:

Related Report:

Cardiac Arrhythmia Monitoring Devices Market Insights 2019, Global and Chinese Analysis and Forecast to 2024

Cardiac Arrhythmia Monitoring Devices Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Cardiac Arrhythmia Monitoring Devices industry with a focus on the Chinese market. The report provides key statistics on the market status of the Cardiac Arrhythmia Monitoring Devices manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Cardiac Arrhythmia Monitoring Devices market covering all important parameters.

Read more at:

About Us: allows you to manage and control all corporate research purchases to consolidate billing and vendor management. You can eliminate duplicate purchases and customize your content and license management.

Contact Info:
Name: Arun Hegde
Email: Send Email
Organization: Market Study Report
Address: 4 North Main Street, Selbyville, Delaware 19975 USA
Phone: 1-302-273-0910

Release ID: 88909824